M. Hisaoka et al., Specific but variable expression of h-caldesmon in leiomyosarcomas - An immunohistochemical reassessment of a novel myogenic marker, APPL IMMUNO, 9(4), 2001, pp. 302-308
h-Caldesmon is considered a novel specific marker for tumors with smooth mu
scle differentiation. To reassess its diagnostic use, the authors evaluated
the immunohistochemical expression of h-caldesmon and other myogenic marke
rs (calponin, a-smooth muscle actin, HHF35, and desmin) in 30 leiomyosarcom
as (external soft tissues [15], retroperitoneum [8], uterus [5], other site
s [2]), 26 myofibroblastic lesions, and 26 fibrohistiocytic tumors of varyi
ng biologic potential and histology. In contrast with previous data, h-cald
esmon was expressed only in 11 (36%) of the 30 leiomyosarcomas analyzed, wh
ereas they consistently expressed actins and frequently expressed calponin
(86%) and desmin (76%). Leiomyosarcomas with the expression of h-caldesmon
were well or moderately differentiated and primarily confined to the retrop
eritoneum or uterus. All but one leiomyosarcomas in the external soft tissu
es examined were negative for h-caldesmon, and the h-caldesmon-negative tum
ors showed moderately to poorly differentiated morphology. All myofibroblas
tic lesions examined were negative for h-caldesmon despite their constant e
xpressions of at least one of the other markers. h-Caldesmon was not expres
sed in fibrohistiocytic tumors either, although focal positivity for the ot
her markers was seen in subsets of the tumors. Thus, h-caldesmon can be reg
arded as a specific myogenic marker. However, one should be aware that the
expression of h-caldesmon in leiomyosarcomas can be more variable according
to their locations and/or extent of smooth muscle differentiation than con
sidered previously.